Last Chance to Register for SSLLC’s Genetown 50.
Lot 1 begins closing at 10am (EST). Soft close and popcorn bidding activated.
Nothing interest you in this auction? Check out our auction for next week below.
Got surplus equipment? Buying and selling your equipment is now simplified. Our trained sales experts are ready and waiting to guide you through the process of selling your surplus equipment. It can be as simple as 1-2-3-4.
Click the link below and tell us about your surplus assets and a member of our team will be in touch shortly.
SELL YOUR EQUIPMENT
Or Call 401.526.0055 and speak to a Sales Representative.
ACE VPG 35 GLASS VESSEL
- Manufacturer: ACE
- Model: VPG 35
- Product Code: 247704
HEINKEL INVERTING FILTER CENTRIFUGE
- Make: Heinkel
- Model: HF300.1
- Serial #: 1044-12
- Year: 1993
- Hastelloy C-22 Construction
- 300mm (12″) bowl diameter
- 6.6. liter bowl capacity
- .1 sq meter surface area
MILLIPORE MILLI-Q BIOCEL
- Make: Millipore
- Model Milli-Q Millipore Biocel
- Year: 2006
- Digital Controls
- Includes: manual and consumable accessories
- Electric Ratings: 120V, 60hz
THERMO ELECTRON MODEL 6557 OVEN
- Make: Thermo Electron
- Model: 6557
- Precision Oven
- Year: 2006
- Digital controls
- Power: 115V, 50/60hz
Please take a quick second to answer our brief survey in order to help us provide more relevant contact via our SSLLC Blog
Click here to take survey
We thank you in advance and look forward to hearing your feedback!
COZZOLI MACHINE CO. VIAL WASHER
- Make: Cozzoli Machine Company
- Model: GW24
- Serial #: GW24-271
- Allen Bradley 600 Controls
- Trays: (3) 3mL Vial # 10890, (3) 3mL Vial # 10371
MENGIBAR MODEL 1150 VIAL WASHER
- Make: Mengibar
- Model: 1150
- Serial #: 9702 RW
- Controls: Allen Bradley Panel View 550
- Change Parts: All Sizes
- Include Casettes and Sprayers: 125cc, 20mL, 30cc, 5cc, 13mm, (2) 5cc, (2) 10cc, 50cc, 60cc, 3cc
- Check out our website for more information…
WHATMAN 75-36 HYDROGEN GENERATOR
The drug helps speed recovery for patients after bowel resection for benign or malignant colorectal or small bowel disease. The new approval means the drug could also be used for patients following a complex surgery called radical cystectomy, which involves removing a part of the bowel in order reconstruct the urinary tract. Entereg is the first and only FDA-approved agent for this use.
The Lexington, Mass.-based company (Nasdaq: CBST)is positioning the drug as one that can save hospitals money.
“Delayed GI recovery is one of the most common causes of prolonged hospital stays in patients undergoing major abdominopelvic surgery. We are pleased that doctors will have the option to help speed GI recovery for appropriate patients who have undergone surgeries that included a bowel resection,” Steven Gilman, Executive Vice President of Research and Development and Chief Scientific Officer of Cubist, said in a statement. “At Cubist, we are committed to improving patient outcomes within the hospital setting, and enabling patients to leave the hospital sooner through the use of therapeutics that help put them on the path to good health.”
Entereg was first approved by the FDA in 2008, when it was owned by Adolor Corp. Adolor agreed to be acquired by Cubist in October 2011. Cubist grew revenues for the drug to $40.2 million in 2012 from $32 million in 2011. Cubist has said Entereg sales will hit $100 million by 2017.
Entereg is available only for short-term use in hospitalized patients, because of the potential increased risk of myocardial infarction.